Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information

Background: Pharmacogenomics is the study of how genes affect a person’s response to drugs. This descriptive study assessed whether popular drug information resources provide clinically useful pharmacogenomic (PGx) information. Methods: Four resources (package inserts, Lexicomp, Micromedex 2.0, and...

Full description

Bibliographic Details
Main Authors: Jennifer S. Chang, Duyen-Anh Pham, Maithao T. Dang, Yiting Lu, Sheri VanOsdol, Jaekyu Shin
Format: Article
Language:English
Published: University Library System, University of Pittsburgh 2016-01-01
Series:Journal of the Medical Library Association
Subjects:
Online Access:http://jmla.pitt.edu/ojs/jmla/article/view/367
_version_ 1811303209230139392
author Jennifer S. Chang
Duyen-Anh Pham
Maithao T. Dang
Yiting Lu
Sheri VanOsdol
Jaekyu Shin
author_facet Jennifer S. Chang
Duyen-Anh Pham
Maithao T. Dang
Yiting Lu
Sheri VanOsdol
Jaekyu Shin
author_sort Jennifer S. Chang
collection DOAJ
description Background: Pharmacogenomics is the study of how genes affect a person’s response to drugs. This descriptive study assessed whether popular drug information resources provide clinically useful pharmacogenomic (PGx) information. Methods: Four resources (package inserts, Lexicomp, Micromedex 2.0, and Epocrates) were evaluated for information about twenty-seven drugs. Results: There was wide variability of PGx information. Whereas Lexicomp included relevant PGx biomarker information for all 27 drugs, Epocrates did in less than 50% of the drugs. None of the resources had monographs that fully incorporated Clinical Pharmacogenomics Implementation Consortium (CPIC) recommendations in more than 30% of the drugs. Conclusion: Lexicomp appears to be most useful PGx drug information resource, but none of the resources are sufficient.
first_indexed 2024-04-13T07:42:40Z
format Article
id doaj.art-953de7e2aabe4fff8c4b1ef751018a2d
institution Directory Open Access Journal
issn 1536-5050
1558-9439
language English
last_indexed 2024-04-13T07:42:40Z
publishDate 2016-01-01
publisher University Library System, University of Pittsburgh
record_format Article
series Journal of the Medical Library Association
spelling doaj.art-953de7e2aabe4fff8c4b1ef751018a2d2022-12-22T02:55:49ZengUniversity Library System, University of PittsburghJournal of the Medical Library Association1536-50501558-94392016-01-011041210Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic informationJennifer S. Chang0Duyen-Anh Pham1Maithao T. Dang2Yiting Lu3Sheri VanOsdol4Jaekyu Shin5Pharmacy Student (at the time of the study), Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, 533 Parnassus Avenue, U-585, Box 0622, San Francisco, CA 94143-0622Pharmacy Student (at the time of the study), Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, 533 Parnassus Avenue, U-585, Box 0622, San Francisco, CA 94143-0622Pharmacy Student (at the time of the study), Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, 533 Parnassus Avenue, U-585, Box 0622, San Francisco, CA 94143-0622Pharmacy Student (at the time of the study), Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, 533 Parnassus Avenue, U-585, Box 0622, San Francisco, CA 94143-0622Assistant Professor of Clinical Pharmacy (at the time of the study), Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, 533 Parnassus Avenue, U-585, Box 0622, San Francisco, CA 94143-0622Associate Professor of Clinical Pharmacy, Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, 533 Parnassus Avenue, U-585, Box 0622, San Francisco, CA 94143-0622Background: Pharmacogenomics is the study of how genes affect a person’s response to drugs. This descriptive study assessed whether popular drug information resources provide clinically useful pharmacogenomic (PGx) information. Methods: Four resources (package inserts, Lexicomp, Micromedex 2.0, and Epocrates) were evaluated for information about twenty-seven drugs. Results: There was wide variability of PGx information. Whereas Lexicomp included relevant PGx biomarker information for all 27 drugs, Epocrates did in less than 50% of the drugs. None of the resources had monographs that fully incorporated Clinical Pharmacogenomics Implementation Consortium (CPIC) recommendations in more than 30% of the drugs. Conclusion: Lexicomp appears to be most useful PGx drug information resource, but none of the resources are sufficient.http://jmla.pitt.edu/ojs/jmla/article/view/367Pharmacogenomics, Biomarkers, Drug Information Services, Genetic Testing
spellingShingle Jennifer S. Chang
Duyen-Anh Pham
Maithao T. Dang
Yiting Lu
Sheri VanOsdol
Jaekyu Shin
Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information
Journal of the Medical Library Association
Pharmacogenomics, Biomarkers, Drug Information Services, Genetic Testing
title Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information
title_full Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information
title_fullStr Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information
title_full_unstemmed Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information
title_short Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information
title_sort evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information
topic Pharmacogenomics, Biomarkers, Drug Information Services, Genetic Testing
url http://jmla.pitt.edu/ojs/jmla/article/view/367
work_keys_str_mv AT jenniferschang evaluationofpopulardruginformationresourcesonclinicallyusefulandactionablepharmacogenomicinformation
AT duyenanhpham evaluationofpopulardruginformationresourcesonclinicallyusefulandactionablepharmacogenomicinformation
AT maithaotdang evaluationofpopulardruginformationresourcesonclinicallyusefulandactionablepharmacogenomicinformation
AT yitinglu evaluationofpopulardruginformationresourcesonclinicallyusefulandactionablepharmacogenomicinformation
AT sherivanosdol evaluationofpopulardruginformationresourcesonclinicallyusefulandactionablepharmacogenomicinformation
AT jaekyushin evaluationofpopulardruginformationresourcesonclinicallyusefulandactionablepharmacogenomicinformation